Tagged with M

Malaysia Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination.   We have a population of 32 million which represents a third of the world’s genomics Dr Akhmal Yusof, CRM Dr…

Opinion Richard Saynor, Senior Vice President, Classic and Established Products at GSK urges big pharma to weigh in on improving global health and well-being to achieve the United Nations Sustainable Development Goals.  On the part of pharmaceutical companies, we have a responsibility to help people gain access to high-quality healthcare and…

China China’s stupendous economic resurgence over the past four decades never ceases to awe, but what has captured attention in recent years has been the country’s international awakening. Against a nasty backdrop of intensifying populist nationalism, right-wing radicalism and trade protectionism in many advanced economies, Chinese President Xi Jinping’s surprising 2017…

China Cash has always ruled the start-up world and when it comes to the healthcare and life sciences sphere, the heavy investment required for R&D and the long timelines make it even more so. Luckily, China is now the second-largest VC market in the world, and a recent Preqin report highlighted that USD 65…

Malaysia Shahnas Oli Mohamed, the managing director of Natural Wellness Holdings Sdn Bhd, expresses the important work that Natural Wellness has done to provide natural healthcare products to Malaysian patients, including a specific halal line to satisfy the community’s needs in that area. She also identifies the opportunities Natural Wellness will…

Malaysia David Ho, managing director of Hovid, introduces the success story of his family-owned company, which started at a Chinese herbal tea manufacturer and became one of the biggest local generic manufacturers in Malaysia. He also indicates his future plan to increase the company’s international presence.   We are now present…

Spain The global rich list is splattered with household names who have built their reputation not only through business acumen but through eye-catching purchases such as Steve Balmer’s record buyout of the LA Clippers basketball team for a whopping USD two billion in 2016 or Roman Abramovich´s spectacular 162.5 metres yacht…

Spain LEO Pharma’s Paolo Cionini discusses recent structural changes in the dermatology specialist’s Europe South operations, the importance of Spain to the regional group, and the nation’s digital capabilities.   The biggest need in Europe and the US is around new products and technologies in advanced therapies. LEO Pharma has undergone…

Malysia Dr Goh Pik Pin, director of the Clinical Research Centre (CRC), and Dr Salina Abd Aziz, consultant psychiatrist and chairperson, MOH Medical Research Ethics Committee, and head, CRC Hospital Kuala Lumpur, highlight the main improvements of the CRC as well as the clinical research environment in Malaysia since 2014. Dr…

Turkey With the construction of state-of-the-art public and private hospitals, Turkey is poised to become a global leader in medical tourism.   Turkey has always been a popular tourist destination, given its unrivaled history and cultural appeal, and now, after years of large-scale investments by both the private and public sector,…

Malaysia The Top 10 pharma importers in Malaysia for 2017 ranked by total revenue and market share. Pfizer holds top spot with 10.2% market share and USD 108 million in revenue, followed by MSD and Bayer. The top 10 pharma wholesalers in Malaysia for 2017 ranked by total revenue and market…

Malaysia Tunku Naquiyuddin and Tunku Mohamed Alauddin, respectively executive chairman and managing director of the Antah Healthcare Group highlight the importance of close business relationships between stakeholders in Malaysia and its role in the success of the group. The current focus of the company is to expand its warehousing facilities, increase…